<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0100724'>Thrombophilia</z:hpo> may be associated with <z:hpo ids='HP_0004416'>premature atherosclerosis</z:hpo>, an increased susceptibility to primary <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> and an increased failure rate for peripheral vascular or endovascular interventions </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to determine the prevalence of <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> in patients with <z:hpo ids='HP_0004417'>intermittent claudication</z:hpo> (IC) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: This was a prospective study of 116 consecutive new patients (70 men; median age 65 (range 43-84) years) referred to this regional vascular surgery unit with IC </plain></SENT>
<SENT sid="3" pm="."><plain>Patients on <z:chebi fb="8" ids="10033">warfarin</z:chebi>, or who had previously undergone lower limb reconstruction and/or angioplasty, were excluded </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: <z:hpo ids='HP_0100724'>Thrombophilia</z:hpo> was demonstrated in 24 patients (21 per cent) </plain></SENT>
<SENT sid="5" pm="."><plain>The commonest abnormality (15 patients, 13 per cent) was a raised level of anticardiolipin antibody (ACLA) (11 immunoglobulin (Ig) M, four IgG) </plain></SENT>
<SENT sid="6" pm="."><plain>Other abnormalities comprised: <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (one), <z:hpo ids='HP_0005543'>protein C deficiency</z:hpo> (two), <z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">protein S deficiency</z:e> (two), activated protein C resistance (one) and factor V Leiden heterozygosity (three) </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> abnormalities were confirmed on repeat testing </plain></SENT>
<SENT sid="8" pm="."><plain>No patient had a history of <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>There was no statistically significant relationship between ACLA status and age, sex, ankle : brachial pressure index, previous <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> or <z:hpo ids='HP_0001297'>stroke</z:hpo>, previous carotid endarterectomy or coronary artery surgery, serum cholesterol, current use of antiplatelet agents or current smoking status </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Almost one-quarter of new patients referred to this regional vascular unit with IC have <z:hpo ids='HP_0100724'>thrombophilia</z:hpo>; over half of those affected have a raised ACLA level compatible with the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>At present, the clinical significance and management implications of these abnormalities remain unknown </plain></SENT>
</text></document>